Drugmaker Dr Reddy's Laboratories said it has signed a commercialisation deal with Australia's Hatchtech for the latter's prescription head lice product Xeglyze Lotion. - See more at: http://ways2capital-review.blogspot.in/2015/09/dr-reddys-signs-commercialisation-deal.html#sthash.HGFJaUwH.dpuf
Diabetes drug metformin could help reduce the effects of uveitis, an inflammation of the tissues just below the outer surface of the eyeball. Uveitis causes 10 to 15 percent of all cases of blindness in the United States, and is responsible for an even higher proportion of blindness globally.
Dr Reddy's Laboratories submitted a response to the US health regulator on a warning letter it had received last month. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/dr-reddys-submits-response-to-usfda-on.html#sthash.cHBBZ00E.dpuf